Purpose
This study aims to investigate the effects of the different doses of esketamine on postoperative quality of recovery in patients undergoing modified radical mastectomy.
Methods
Ninety-nine female patients were randomly allocated to three groups: the low-dose esketamine group (group E
1
) (0.5 mg/kg loading, 2 µg/kg/h infusion), the high-dose esketamine group (group E
2
) (0.5 mg/kg loading, 4 µg/kg/h infusion), the control group (group C) (received normal saline). The primary outcome was the quality of recovery-15 (QoR-15) scores on postoperative day 1 (POD1) and days 3 (POD3). The secondary outcomes were the sleep quality scores on POD1, bispectral index (BIS) value at 10, 30, and 60 min after operation, numeric rating scale (NRS) pain scores within 24 h after surgery, nausea, vomiting, drowsiness, nightmare, and intraoperative awareness.
Results
The total QoR-15 scores were higher in group E
1
and group E
2
than in group C on POD1 and POD3 (
P
<0.05). The sleep quality scores on POD1 and BIS value at 10, 30, and 60 min after operation were higher in group E
1
and group E
2
than in group C (
P
<0.05). The NRS pain scores at 2, 4 and 6 h after surgery in group E
1
and at 2, 4, 6, 12 and 24 h after surgery in group E
2
were lower than in group C (
P
<0.05). The NRS pain scores at 6, 12 and 24 h after surgery in group E
2
were lower than in group E
1
(
P
<0.05). The incidence of drowsiness was higher in group E
1
and group E
2
than in group C (
P
<0.05).
Conclusion
Esketamine infusion improved to some extent the quality of recovery on POD1 and POD3 in patients undergoing modified radical mastectomy, especially 4 µg/kg/h esketamine was better, but the BIS value and incidence of drowsiness were significantly increased.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.